Christian Angermayer (#3030)
- $ 1 B
- Investments
- Germany
- M
- 48 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Christian Angermayer invests in life sciences, fintech, AI, psychedelics and cryptocurrencies through his family office Apeiron Investment Group. He made his first millions cofounding biotech firm Ribopharma with his college professors; he sold his stake when it merged with Alnylam in 2003. His Malta-based Apeiron owns shares in several publicly traded firms and private companies in the U.S., Germany, Canada and Australia. His holdings include psychedelics biopharma firm Atai Life Sciences and blockchain holding company Samara, alongside co-investor Mike Novogratz. He owns an extensive art collection that includes ancient artifacts highlighting the role that psychedelics have played in human history.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Christian Angermayer’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Christian Angermayer’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.2B
(May 4, 2026)
© Iconic Billionaires